| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A commission on vector-borne infections
|
The Lancet Infectious Diseases,
|
|
|
25 |
8 |
p. 827
|
artikel
|
| 2 |
Africa to integrate cholera and mpox response
|
Nakkazi, Esther
|
|
|
25 |
8 |
p. e447
|
artikel
|
| 3 |
Ageing in a pandemic
|
Sherwood-Martin, Hollie
|
|
|
25 |
8 |
p. 846
|
artikel
|
| 4 |
Balancing promise and peril: risk management in India's BPaL introduction
|
Tirlangi, Praveen K
|
|
|
25 |
8 |
p. 840-841
|
artikel
|
| 5 |
Closing the pertussis immunity gap: vaccine equity saves infant lives
|
Muloiwa, Rudzani
|
|
|
25 |
8 |
p. 835-836
|
artikel
|
| 6 |
Correction to Lancet Infect Dis 2024; 24: 1201–12
|
|
|
|
25 |
8 |
p. e444
|
artikel
|
| 7 |
Correction to Lancet Infect Dis 2025; 25: 494
|
|
|
|
25 |
8 |
p. e444
|
artikel
|
| 8 |
Correction to Lancet Infect Dis 2025; published online June 20. https://doi.org/10.1016/S1473-3099(25)00240-3
|
|
|
|
25 |
8 |
p. e444
|
artikel
|
| 9 |
COVID-19 mortality in Africa and Asia
|
Vento, Sandro
|
|
|
25 |
8 |
p. e439
|
artikel
|
| 10 |
COVID-19 mortality in Africa and Asia – Authors' reply
|
Bejon, Philip
|
|
|
25 |
8 |
p. e440
|
artikel
|
| 11 |
COVID-19: the challenges of a digital pandemic
|
Dunsmuir, Henrietta
|
|
|
25 |
8 |
p. 844
|
artikel
|
| 12 |
14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy study
|
Eng, Virak
|
|
|
25 |
8 |
p. 884-895
|
artikel
|
| 13 |
Debt crisis hinders infectious disease response
|
Burki, Talha
|
|
|
25 |
8 |
p. e448-e449
|
artikel
|
| 14 |
Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension
|
Luetkemeyer, Anne F
|
|
|
25 |
8 |
p. 873-883
|
artikel
|
| 15 |
DoxyPEP open-label extension: well done is better than well said
|
Burchell, Ann N
|
|
|
25 |
8 |
p. 830-832
|
artikel
|
| 16 |
Efficacy and safety of individualised versus standard 10-day antibiotic treatment in children with febrile urinary tract infection (INDI-UTI): a pragmatic, open-label, multicentre, randomised, controlled, non-inferiority trial in Denmark
|
Sethi, Naqash Javaid
|
|
|
25 |
8 |
p. 925-935
|
artikel
|
| 17 |
Elise Sampson
|
Bagcchi, Sanjeet
|
|
|
25 |
8 |
p. 842
|
artikel
|
| 18 |
Expanding human papillomavirus vaccine options
|
Vorsters, Alex
|
|
|
25 |
8 |
p. 829-830
|
artikel
|
| 19 |
Global progress on neglected tropical diseases
|
Jesudason, Timothy
|
|
|
25 |
8 |
p. e445
|
artikel
|
| 20 |
High-dose primaquine reduces vivax relapses: time for change
|
Commons, Robert J
|
|
|
25 |
8 |
p. 832-833
|
artikel
|
| 21 |
Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9–14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial
|
Agbenyega, Tsiri
|
|
|
25 |
8 |
p. 861-872
|
artikel
|
| 22 |
Individualised duration of treatment in febrile urinary tract infection: ready for prime time?
|
Rodríguez-Baño, Jesús
|
|
|
25 |
8 |
p. 837-838
|
artikel
|
| 23 |
Infectious disease surveillance update
|
McQuillan, Cahal
|
|
|
25 |
8 |
p. e449
|
artikel
|
| 24 |
Intention-to-diagnose and distinct research foci in diagnostic accuracy studies
|
Evans, Scott R
|
|
|
25 |
8 |
p. e472-e481
|
artikel
|
| 25 |
Long COVID treatment trials: still more questions than answers?
|
Bramante, Carolyn T
|
|
|
25 |
8 |
p. 838-840
|
artikel
|
| 26 |
Long-term infectious sequelae after SARS-CoV-2 infection should be considered in mild cases too
|
Chodick, Gabriel
|
|
|
25 |
8 |
p. 828-829
|
artikel
|
| 27 |
Maternal mastitis and streptococcal toxic shock syndrome risk from breastfeeding children with scarlet fever: case report and literature review
|
Dahmann, Sonja
|
|
|
25 |
8 |
p. e482-e488
|
artikel
|
| 28 |
Neuroinvasive Oropouche virus in a patient with HIV from extra-Amazonian Brazil
|
Gatti, Felipe Donateli
|
|
|
25 |
8 |
p. e441-e442
|
artikel
|
| 29 |
Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial
|
Sawano, Mitsuaki
|
|
|
25 |
8 |
p. 936-946
|
artikel
|
| 30 |
Rates of infection with other pathogens after a positive COVID-19 test versus a negative test in US veterans (November, 2021, to December, 2023): a retrospective cohort study
|
Cai, Miao
|
|
|
25 |
8 |
p. 847-860
|
artikel
|
| 31 |
Recognising Aspergillus udagawae in a child with chronic granulomatous disease
|
Gao, Qi
|
|
|
25 |
8 |
p. e489-e490
|
artikel
|
| 32 |
Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies
|
Ljungman, Per
|
|
|
25 |
8 |
p. e451-e462
|
artikel
|
| 33 |
Research in brief
|
Venkatesan, Priya
|
|
|
25 |
8 |
p. e450
|
artikel
|
| 34 |
Rethinking the evidence on COVID-19 in Africa
|
Bejon, Philip
|
|
|
25 |
8 |
p. e463-e471
|
artikel
|
| 35 |
Tackling the burden of β-lactam allergy labels
|
Li, Philip H
|
|
|
25 |
8 |
p. 834-835
|
artikel
|
| 36 |
The burden of β-lactam allergy labels in health care: a systematic review and meta-analysis
|
Fu, Mengyuan
|
|
|
25 |
8 |
p. 896-908
|
artikel
|
| 37 |
The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial
|
Saso, Anja
|
|
|
25 |
8 |
p. 909-924
|
artikel
|
| 38 |
Virological characteristics of the SARS-CoV-2 NB.1.8.1 variant
|
Uriu, Keiya
|
|
|
25 |
8 |
p. e443
|
artikel
|
| 39 |
Women of the shadow pandemic in Zimbabwe
|
Ashley-Norman, Phoebe
|
|
|
25 |
8 |
p. 845
|
artikel
|
| 40 |
World-first gonorrhoea vaccine to be rolled out in England
|
Kirby, Tony
|
|
|
25 |
8 |
p. e446
|
artikel
|
| 41 |
Xiang-Sheng Chen—controlling STIs in China
|
Kirby, Tony
|
|
|
25 |
8 |
p. 843
|
artikel
|
Tijdschrift beschrijving